# Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)

> **NCT04871035** · — · RECRUITING · sponsor: **University of Ulm** · enrollment: 20 (estimated)

## Conditions studied

- GBS

## Interventions

- **DEVICE:** Immunoadsorption
- **DEVICE:** Plasma Exchange

## Key facts

- **NCT ID:** NCT04871035
- **Lead sponsor:** University of Ulm
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-28
- **Primary completion:** 2027-09-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04871035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04871035, "Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04871035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*